Antibody-drug conjugate may provide new treatment option for pancreatic cancer patients
Monday, October 21, 2013 - 12:30
in Health & Medicine
Patients with pancreatic cancer may benefit from an investigational member of an emerging class of anticancer drugs called antibody-drug conjugates, according to preclinical results.